{
    "title": "J&J issues cautious 2023 forecast, shares fall",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11985661/J-J-lifts-profit-forecast-cancer-drugs-Stelara-buoy-pharma-unit.html",
    "date": "2023-04-18",
    "keywords": [
        "company",
        "cancer",
        "unit",
        "jampj",
        "device",
        "inflation",
        "bhanvi",
        "satija",
        "impact",
        "profit",
        "forecast",
        "drug",
        "stelara",
        "firstquarter",
        "bankruptcy",
        "filing",
        "consumer",
        "health",
        "vaccine",
        "treatment",
        "johnson",
        "tuesday",
        "inflationdriven",
        "year",
        "healthcare",
        "conglomerate",
        "decline",
        "blockbuster",
        "crohns",
        "protection",
        "decliner",
        "dow",
        "index",
        "drugmaker",
        "manufacturer",
        "midpoint",
        "officer",
        "joseph",
        "wolk",
        "conference",
        "call",
        "competition",
        "imbruvica",
        "concern",
        "couple",
        "analyst",
        "john",
        "boylan",
        "side",
        "input",
        "healing",
        "process",
        "place",
        "recovery",
        "staffing",
        "quarter",
        "loss",
        "charge",
        "management",
        "talc",
        "cause",
        "spinoff",
        "revenue",
        "covid19",
        "beat",
        "street",
        "prostate",
        "erleada",
        "myeloma",
        "darzalex",
        "line",
        "covid",
        "traction",
        "price",
        "basis",
        "share",
        "reporting",
        "mishra",
        "bengaluru",
        "editing",
        "kalluvila",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}